BDTX - Black Diamond Therapeutics - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart

BDTX is currently covered by 5 analysts with an average price target of $10.43. This is a potential upside of $9.12 (696.18%) from yesterday's end of day stock price of $1.31.

Black Diamond Therapeutics's activity chart (see below) currently has 60 price targets and 56 ratings on display. The stock rating distribution of BDTX is 100% BUY.

Stock Analyst Price Targets - Review

Analysts' price targets on this stock were met 4.25% of the time, taking 15.24 days on average.

Highest price target for BDTX is $14, Lowest price target is $7, average price target is $10.43.

Most recent stock forecast was given by ROBERT BURNS from HC WAINWRIGHT on 29-Oct-2026. First documented stock forecast 24-Feb-2020.

Best performing analysts who are covering BDTX - Black Diamond Therapeutics:

Kelsey Goodwin Ilya Zubkov Laura Prendergast Eric Joseph

Currently out of the existing stock ratings of BDTX, 6 are a BUY (100%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Buy Since 22-Nov-2023

$11

$9.69 (739.69%)

$11

23 days ago
(29-Oct-2026)

0/14 (0%)

$9.14 (491.40%)

Buy Since 30-Sep-2025

$7

$5.69 (434.35%)

$6

7 months 29 days ago
(23-Mar-2026)

0/2 (0%)

$4.85 (225.58%)

Buy Since 12-Sep-2023

$14

$12.29 (718.71%)

$16

8 months 4 days ago
(17-Mar-2026)

0/10 (0%)

$11.77 (527.80%)

Buy Since 18-Nov-2025

$8

$6.29 (367.84%)

$9

10 months 5 days ago
(16-Jan-2026)

0/2 (0%)

$5.44 (212.50%)

Buy Since 14-Dec-2023

11 months 17 days ago
(04-Dec-2025)

1/6 (16.67%)

$5.12 (177.78%)

83

Show more analysts

Please expand the browser size to see the chart

What is BDTX (Black Diamond Therapeutics) average time for price targets to be met?

On average it took 15 days for the stock forecasts to be reached, with an average price target met ratio of 4.25%.

Which analyst most recently updated their price target on BDTX (Black Diamond Therapeutics)?

Robert Burns

Which analyst has the most public recommendations on BDTX (Black Diamond Therapeutics)?

Robert Burns works at HC WAINWRIGHT and has 40 price targets and 27 ratings on BDTX

Which analyst is the currently most bullish on BDTX (Black Diamond Therapeutics)?

Eric Joseph with the highest potential upside of $22.69

Which analyst is the currently most reserved on BDTX (Black Diamond Therapeutics)?

Bradley Canino with the lowest potential downside of -$0
✖

To continue looking at which analysts cover the stock please register to the basic or advanced membership

To continue looking at analysts data please register to the advanced membership

What is AnaChart?